WuXi Biologics (Cayman) Inc. (WXXWY) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    WuXi Biologics (Cayman) I...

    OTC: WXXWY · Real-Time Price · USD
    8.45
    0.60 (7.64%)
    At close: Aug 29, 2025, 3:50 PM
    8.60
    1.78%
    After-hours: Aug 29, 2025, 12:43 PM EDT

    WuXi Biologics (Cayman) Cash Flow Statement

    Financials in CNY. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q4 2024 Q2 2024 Q4 2023 Q2 2023 Q4 2022 Q2 2022 Q4 2021 Q2 2021
    Period Ending Dec 31, 2024 Jun 30, 2024 Dec 31, 2023 Jun 30, 2023 Dec 31, 2022 Jun 30, 2022 Dec 31, 2021 Jun 30, 2021
    Net Income
    		 4.83B 3.2B 3.4B 3.59B 4.42B 4.08B 3.39B 2.79B
    Depreciation & Amortization
    		 1.44B 1.37B 1.17B 884.41M 800.67M 650.61M 481.78M 421.28M
    Stock-Based Compensation
    		 1.22B 1.33B 1.27B 1.33B 1.3B 954.84M 577.95M 378.45M
    Other Working Capital
    		 -1.16B -150.57M -301.13M -250.71M -100.14M -551.77M -551.77M 4.23M
    Other Non-Cash Items
    		 -1.47B -1.81B -279.1M 3.16B 1.12B 1.18B 1.76B 756.12M
    Deferred Income Tax
    		 n/a n/a n/a 1.3B 1.3B 1.87B 1.87B 1.95B
    Change in Working Capital
    		 -800.5M -448.17M -896.35M -2.55B -2.1B -2.78B -2.78B -2.1B
    Operating Cash Flow
    		 5.22B 3.64B 4.67B 6.42B 5.54B 4.09B 3.43B 2.25B
    Capital Expenditures
    		 -3.93B -3.98B -4.23B -5.3B -5.87B -5.12B -6.51B -7.18B
    Cash Acquisitions
    		 n/a n/a n/a -1.04M -131.49M -275.81M -2.18B -2.19B
    Purchase of Investments
    		 -11.43B -7.54B -15.08B -7.54B n/a n/a n/a n/a
    Sales Maturities Of Investments
    		 10.89B 7.82B 15.64B 7.82B n/a n/a n/a n/a
    Other Investing Acitivies
    		 524.28M 1.62B 261.99M -229.54M 91.62M 1.17B -913.26M -1.55B
    Investing Cash Flow
    		 -3.94B -2B -3.23B -5.16B -5.91B -4.22B -9.6B -10.93B
    Debt Repayment
    		 490.1M -478.73M -818.45M -409.23M -11.57M -11.57M 326.83M 326.83M
    Common Stock Repurchased
    		 -1.77B -1.69B -916.92M -2.57B -2.8B -3.21B -2.52B n/a
    Dividend Paid
    		 n/a n/a n/a n/a n/a n/a n/a n/a
    Other Financial Acitivies
    		 -1.49B 1.68B 3.7B 1.59B 224.44M -5.28M 10.4B 16.41B
    Financial Cash Flow
    		 -2.75B -495M 1.96B -1.39B -2.59B -3.23B 8.21B 16.74B
    Net Cash Flow
    		 8.28B 12.43B 6.55B 1.53B -2.61B -3.15B 1.91B 7.57B
    Free Cash Flow
    		 1.29B -346.67M 437.2M 1.12B -326.72M -1.03B -3.08B -4.94B

    Add to Watchlist